UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) ~~OF THE SECURITIES EXCHANGE ACT OF 1934~~

~~Date~~OF ofTHE ~~Report~~SECURITIES ~~(Date~~EXCHANGE ofACT ~~earliest~~OF ~~event reported): March 13, 2024~~ 1934

Date of Report (Date of earliest event reported): March 19, 2024

CUE HEALTH INC.

(Exact name of Registrant, as specified in its charter)

Delaware

001-40824

27-1562193

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification Number)

Mailing address:

4980 Carroll Canyon Rd. Suite 100 San Diego, CA 92121 (Address of principal executive offices)

~~Suite~~Registrant’s ~~100~~telephone number, including area code: (858) 412-8151

San Diego, CA 92121

(Address of principal executive

offices)

Registrant's telephone number, including area code: (858) 412-8151

Former name or address, if changed since last report: Not Applicable.

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

Common Stock, par value $0.00001 per share

HLTH

Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 25.02 ~~Results~~. Departure of ~~Operations~~Directors ~~and~~or ~~Financial~~Certain ~~Condition~~Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 13 19, 2024, Cue Health Inc. (~~"Cue~~the ~~Health"~~“Company”) orannounced that Ayub Khattak is stepping down as Chief Executive Officer, President and Chairman of the ~~"Company")~~Board, ~~issued~~effective aimmediately. ~~press~~Mr. Khattak ~~release~~will ~~announcing~~remain as a member of the ~~Company’s~~Board ~~financial~~of ~~results~~Directors. ~~for~~On March 20, 2024, the ~~fourth~~Company ~~quarter~~appointed co-founder and ~~full~~current ~~year~~Chief ~~ended~~Product ~~December~~Officer, 31Clint Sever, ~~2023~~as Chief Executive Officer. A ~~copy~~Mr. Sever’s ofbiography ~~the~~can ~~press~~be ~~release~~found isin ~~furnished~~the ~~herewith~~Company’s asproxy ~~Exhibit~~statement ~~99.1~~filed with the Securities and isExchange ~~incorporated~~Commission byon ~~reference~~April ~~herein~~25, 2023.

~~The~~A ~~information~~copy ~~contained this Current Report on Form 8-K and in the accompanying exhibit are “furnished” and shall not be deemed “filed” for purposes~~ of ~~Section 18 of~~ the ~~Securities~~related ~~Exchange~~press ~~Act~~release ofannouncing ~~1934, as amended (~~the ~~“Exchange~~leadership ~~Act”),~~transition orand ~~otherwise subject to~~ the ~~liabilities~~appointment of ~~that~~Board ~~section,~~advisors ~~and~~is ~~shall~~attached ~~not~~hereto ~~be incorporated by reference in any filing under the Securities Act of 1933,~~ as ~~amended, or the Exchange Act regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing~~Exhibit 99.1.

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
ExhibitNumber	Description
99.1		Press Release issued by Cue Health dated March 13, 2024.
99.1*	Press Release issued by Cue Health Inc. dated March 20, 2024.
104	Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL) document.	~~Cover Page Interactive Data File (embedded within the Inline XBRL Document).~~

2* Furnished herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	~~Cue Health Inc.~~	Cue Health Inc.
Date: March 13, 2024	By:		/s/ Aasim Javed
Date: March 20, 2024		By:	/s/ Aasim Javed
	~~Name:~~	Name:	Aasim Javed
	~~Title:~~	Title:	Chief Financial Officer

Filing Compare · Cue Health Inc.